Anti-CHIKV [3E7b]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (4)
- Inventor Info
Info
Catalogue Number | 153198 |
Applications | ELISA IHC Fn WB |
Antigen/Gene or Protein Targets | N218 epitope on E2 protein of CHIKV |
Synonyms | Chikungunya virus |
Reactivity | Virus |
Relevance |
Monoclonal antibody capable of neutralising CHIKV replication and can detect infection of cells. Background and Research Application Chikungunya virus (CHIKV) is an alphavirus which causes febrile illness with severe polyarthralgia, known to be transmitted to humans by mosquito vectors, primarily Aedes aegypti and A. albopictus. Symptoms of chikungunya infection generally initiated 4–7 days after the bite of the mosquito vector and usually include high fever, asthenia, chills, headache, diarrhoea, vomiting and rash. CHIKV gained its infamy from the severe outbreak in the Indian Ocean island of La Re’union in 2005-2006, in which 38.2% of the population was infected and 41.5 million people were documented to have experienced haemorrhagic fever manifestations. Since the re-emergence of CHIKV in La Reunion, epidemic outbreaks of CHIKV infection have been reported globally and CHIKV is now considered endemic in 34 countries across Europe, Australia, Asia and Africa. Anti-CHIKV binds strongly to native CHIKV surface and potently neutralize CHIKV replication. |
Host | Mouse |
Immunogen | Live chikungunya virus |
Immunogen UniProt ID | Q8JUX5 |
Positive Control | Infected BHK cells |
Subclass | IgM |
Myeloma Used | Sp2/0-Ag14 |
Notes |
Production Details Purified using multi-step affinity chromatography with protein A. Storage Conditions Store at -20 degrees frozen. Avoid repeated freeze/thaw cycles. Points of Interest Mouse monoclonal antibodies that are specific to chikungunya virus can be used as a research or diagnostic reagent to detect infection of cells. Concentration 1mg/ml as standard |
Research Area | Parasitology, Virology |
References: 4 entries
Schultz et al. 2020. Viruses. 12(3):. PMID: 32120905.
Jin et al. 2019. Viruses. 11(4):. PMID: 30925717.
A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Europe PMC ID: 26305993
Lam et al. 2015. MAbs. 7(6):1178-94. PMID: 26305993.
Add a reference
References: 4 entries
Schultz et al. 2020. Viruses. 12(3):. PMID: 32120905.
Jin et al. 2019. Viruses. 11(4):. PMID: 30925717.
A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.
Lam et al. 2015. MAbs. 7(6):1178-94. PMID: 26305993.
Add a reference